Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
Clinical trial NCT02689726 · TERMINATED
Trial details
- NCT number
- NCT02689726
- Sponsor
- Genticel
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.